Table 4 Postoperative outcomes
Neostigmine group (n = 34) | Sugammadex group (n = 36) | p-value | |
|---|---|---|---|
Positive tongue depressor testa | 2 (5.9%) | 5 (13.9%) | 0.429 |
Positive swallowing test° | 2 (5.9%) | 4 (11.1%) | 0.674 |
Desaturation after extubation (SpO2 < 90%) | 0 (0%) | 5 (13.9%) | 0.054 |
PONV | 2 (5.9%) | 6 (16.7%) | 0.261 |
Discharge to the ward with oxygen therapy | 18 (52.9%) | 22 (61.1%) | 0.636 |
All respiratory complications | 5 (14.7%) | 5 (13.9%) | 1.000 |
Acute respiratory insufficiency | 1 (2.9%) | 0 (0%) | 0.486 |
Pneumothorax after chest tube removal | 0 (0%) | 1 (2.8%) | 1.000 |
Pleural effusion | 2 (5.9%) | 3 (8.3%) | 1.000 |
Atelectasis | 1 (2.9%) | 0 (0%) | 0.486 |
Pneumonia | 0 (0%) | 1 (2.8%) | 1.000 |
Chylothorax | 1 (2.9%) | 0 (0%) | 0.486 |
Atrial fibrillation | 0 (0%) | 2 (5.5%) | 0.493 |
Chest tube days | 4 [2–5] | 3.5 [3, 4] | 0.990 |
Length of hospital stay (days) | 5 [3.5–6] | 4 [4, 5] | 0.431 |
Clavien-Dindo grade at discharge | |||
Grade 1 | 32 (94.1%) | 32 (88.9%) | |
Grade 2 | 2 (5.9%) | 3 (8.3%) | |
Grade 3 | 0 (0%) | 1 (2.8%) | |
Clavien-Dindo grade at 30 days after surgery | |||
Grade 1 | 31 (91.2%) | 30 (83.3%) | |
Grade 2 | 3 (8.8%) | 1 (2.8%) | |
Grade 3 | 0 | 1 (2.8%) | |
Data not reported | 0 | 4 (11.1%) | |